Towards Healthcare

AI in Diagnostics Key Players, Leadership and Governance

Date : 12 November 2025

Leading Companies in the AI in Diagnostics Market

AI in Diagnostics Market Companies

Market Growth

The global AI in diagnostics market was estimated at US$ 1.12 billion in 2023 and is projected to grow to US$ 12.65 billion by 2034, rising at a compound annual growth rate (CAGR) of 24.64% from 2024 to 2034.

AI in Diagnostics Market Revenue 2023 to 2034

Company Insights

  • In March 2024, Abbott announced the release of GLP Systems Track, a cutting-edge automation solution designed to meet the demands of high-volume laboratories. It seeks to provide greater flexibility, assisting labs in maximizing productivity and efficiency in order to satisfy this expanding demand.
  • In September 2024, in order to extend and enhance its products that utilize artificial intelligence to assist in identifying illnesses, the Indian firm Qure.AI secured $65 million from investors led by Lightspeed Venture Partners and 360 ONE Asset Management.
  • In January 2024, Chief Technology Officer of Siemens Healthineers Peter Schardt officially launched the state-of-the-art lab. The collaborative laboratory will develop open-source AI-based tools to accurately automate the segmentation of anomalous outcomes in neuroimaging data, with a focus on the reliable detection of neurological disorders and the examination of their treatment impact at a population level.
  • In August 2024, leading diagnostics business Healthians is the first in the market to offer a solution like this, having just introduced an AI-driven video analysis function in India. The cutting-edge application will aid users in comprehending their health reports by offering lucid explanations and valuable insights into their test findings.

Latest Announcement by Industry Leaders

Prashant Warier, Co-Founder and CEO of Qure.ai believes that AI in healthcare is still in its infancy, but the potential is vast. He commented that AI brings consistency to the patient’s X-ray or other imaging data reports. He shared that the company will integrate multiple data points to create more holistic AI models. He envisioned that the shift would enable doctors to make more informed decisions by considering a patient’s full medical history with diagnostic imaging.

Recent Developments in the AI in Diagnostics Market

  • In May 2025, Bioheaven 360, a biotechnology startup, collaborated with the All India Institute of Medical Sciences (AIMS), New Delhi, and introduced AI AI-enabled health platform. Thi    s platform will help in early disease diagnosis as well as personalized treatment plans. The key features of this platform are AI-based diagnostic support, adaptive self-learning capabilities, and cumulative risk assessment.
  • In May 2025, a collaboration between Johnson and Johnson Private Limited and Qure.ai was announced by Johnson and Johnson Medtech, where they are focusing on the use of AI-based technology and medical technology for the detection of lung cancer at its treatable stages.
  • In August 2024, Bisam Pharmaceuticals introduced "Quick Vitals," the first health monitoring app in the world driven by AI and deep learning technology, in an attempt to improve digital health. The debut ceremony, which took place at Hyderabad's Hotel Avasa, was a critical turning point in the field of technology and healthcare.
  • In May 2024, an extensive partnership between Quest Diagnostics, a pioneer in DX services, and PathAI, a worldwide supplier of AI-driven pathology technology, was unveiled with the goal of quickening the adoption of digital and AI pathology advancements to enhance the accuracy, speed, and efficiency of cancer and other disease diagnosis.
  • In November 2023, the $30 million financing was obtained by the AI-enabled imaging business Aidoc in order to construct a complete AI imaging model and a new product category based on that model.
  • In August 2022, Artificial Intelligence-powered diagnostics startup Digital Diagnostics secured a total of $130 million in investment after announcing the closing of a $75 million Series B round headed by KRR. The round included participation from biotech-focused 8VC and healthcare-focused Optum Ventures.

Collaborate with our experts to explore the AI in Diagnostics Market at sales@towardshealthcare.com